Novateor Research Laboratories Limited (BOM:542771)
India · Delayed Price · Currency is INR 32.85
+0.20 (0.61%)
At close: May 12, 2026
BOM:542771 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 38.28 | 27.77 | 12.07 | 12.6 | 7.42 |
Other Revenue | -0 | - | - | - | - |
| 38.27 | 27.77 | 12.07 | 12.6 | 7.42 | |
Revenue Growth (YoY) | 37.81% | 130.10% | -4.23% | 69.88% | 295.15% |
Cost of Revenue | 25.23 | 18.61 | 9.41 | 9.55 | 5.28 |
Gross Profit | 13.05 | 9.16 | 2.66 | 3.06 | 2.14 |
Selling, General & Admin | 7.22 | 6.06 | 3.55 | 3.85 | 2.51 |
Other Operating Expenses | 6.87 | 4.41 | 2.41 | 2.69 | -3.07 |
Operating Expenses | 15.94 | 12.07 | 6.77 | 7.39 | 0.02 |
Operating Income | -2.9 | -2.91 | -4.11 | -4.34 | 2.12 |
Interest Expense | -0.86 | -0.5 | -0.29 | -0.06 | -0 |
Interest & Investment Income | - | 4.75 | 4.84 | 4.9 | - |
Other Non Operating Income (Expenses) | 4.89 | -0.21 | 0.02 | -0.11 | -0.01 |
EBT Excluding Unusual Items | 1.14 | 1.13 | 0.46 | 0.4 | 2.12 |
Other Unusual Items | - | - | - | - | -4.72 |
Pretax Income | 1.14 | 1.13 | 0.46 | 0.4 | -2.6 |
Income Tax Expense | 0.12 | 0.31 | 0.17 | 0.03 | -0.32 |
Net Income | 1.01 | 0.82 | 0.29 | 0.37 | -2.28 |
Net Income to Common | 1.01 | 0.82 | 0.29 | 0.37 | -2.28 |
Net Income Growth | 23.72% | 179.18% | -20.06% | - | - |
Shares Outstanding (Basic) | 6 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 5 | 5 |
Shares Change (YoY) | -1.64% | - | 25.20% | -0.52% | -17.64% |
EPS (Basic) | 0.17 | 0.17 | 0.06 | 0.08 | -0.47 |
EPS (Diluted) | 0.17 | 0.14 | 0.05 | 0.08 | -0.47 |
EPS Growth | 21.43% | 180.00% | -34.06% | - | - |
Free Cash Flow | -2.02 | -17.24 | -17.13 | -13.26 | -13.81 |
Free Cash Flow Per Share | -0.34 | -2.85 | -2.83 | -2.74 | -2.84 |
Gross Margin | 34.08% | 32.98% | 22.04% | 24.24% | 28.82% |
Operating Margin | -7.57% | -10.49% | -34.03% | -34.43% | 28.61% |
Profit Margin | 2.64% | 2.94% | 2.43% | 2.91% | -30.79% |
Free Cash Flow Margin | -5.27% | -62.08% | -141.94% | -105.21% | -186.09% |
EBITDA | -1.04 | -1.31 | -3.3 | -3.48 | 2.99 |
EBITDA Margin | -2.73% | -4.70% | -27.32% | -27.62% | 40.27% |
D&A For EBITDA | 1.85 | 1.61 | 0.81 | 0.86 | 0.87 |
EBIT | -2.9 | -2.91 | -4.11 | -4.34 | 2.12 |
EBIT Margin | -7.57% | -10.49% | -34.03% | -34.42% | 28.61% |
Effective Tax Rate | 10.91% | 27.74% | 36.72% | 7.26% | - |
Revenue as Reported | 43.16 | 32.53 | 16.93 | 17.5 | 12.26 |
Advertising Expenses | - | - | - | - | 0.06 |